On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Sofosbuvir-Based DAA Regimens Effective for Achieving 12-Week SVR in Chronic HCV
The results of a recent study indicate that combination DAA regimens that include sofosbuvir are effective for achieving SVR in patients with chronic hepatitis C virus and compensated liver cirrhosis.
Older, Minority Patients More Likely to Miss Anti-VEGF Treatment for nAMD
August 31st 2018Among patients who were lost to follow-up over a year, just 7.4% attended a follow-up visit after the observed 12 months. In the total loss to follow-up patient population, they reported a mean 7.8 injection treatments and 8.5 clinic visits. In patients not lost, they reported a mean 14.3 injections and 17.1 visits.
2018-2019 Flu Vaccine Recommendations from ACIP
August 31st 2018New recommendations from the CDC's Advisory Committee on Immunization Practices reveal that health care providers have the intranasally-administered live attenuated influenza vaccine (LAIV) among their arsenal of available vaccines for the 2018-2019 flu season.
Alcon Withdraws Surgical Glaucoma Micro-Stent After New COMPASS Post-Analysis
August 29th 2018The COMPASS-XT five-year analysis reported that patients treated with the micro-stent experienced statistically significant loss of endothelial cells compared to the patients treated with lone cataract surgery.
High Cost of Hepatitis C Drugs Leads to Lengthy Battles for Access to Therapies
August 29th 2018Direct-acting antivirals have been a life-changing breakthrough for patients with chronic hepatitis C virus infection. However, the high cost of the drugs has led many patients down a path of appeals and battles with insurers.